If We Do Not Prevent Liver Disease Now, the World Will Face Devastating Loss of Both Life and Financial Resources Global Liver Institute’s “Global State of Liver Health” Report Exposes Alarming...
Global Liver Institute Recognized as a Healthy People 2030 Champion (Washington, DC – October 4, 2022) — Global Liver Institute (GLI), the premier patient-led liver health nonprofit operating...
Rates of Liver Cancers Are Going Up – and Communities of Color Face the Most Risk Global Liver Institute Launches 5th Annual #OctoberIs4Livers Campaign: Driving Equity in Liver Cancers Washington,...
After brushing off the symptoms of shoulder pain, fatigue, and GI issues as part of my career as a paramedic, I eventually scheduled an appointment with my primary care physician in 2009 when I...
St. Patrick’s Day seems to be a recurring theme throughout my liver cancer journey: I was diagnosed with hepatocellular carcinoma on March 17, 2017 and exactly one year later, I received the...
“You have liver cancer.” It’s a sentence that nobody wants to hear, but far too many people have heard (likely hundreds of thousands this year). Despite the prominent position that cancer has played...
People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years...
GLI Recognizes and Supports Primary Biliary Cholangitis Day Global Liver Institute (GLI) is proud to support liver patients worldwide in recognition of International Primary Biliary Cholangitis...
Global Liver Institute Congratulates Dr. Monica Bertagnolli for Imminent Appointment as Director of the National Cancer Institute Washington, DC – August 12, 2022 – As leaders in the liver cancers...
Recent News
Congress begins Fiscal Year 2025 appropriations process and the Administration approves new treatments improving the lives of liver disease patients. Join Global Liver Institute to Push Congress to Advance Priority Bills and Support Agency Efforts.Congress finalizes...
New App Helps Predict Pediatric Transplant Need Celebrating the repurposed use of Livmarli for pediatric rare liver disease patients Global Liver Institute (GLI) celebrates a major breakthrough with the U.S. FDA’s approval for Mirum Pharmaceuticals’s...
The U.S. FDA approves Madrigal Pharmaceuticals Rezdiffra™ (resmetirom) as the FIRST NASH therapeutic option in the U.S. This breakthrough follows years of NASH patient-led multi-stakeholder advocacy and partnership with researchers in drug development. The hope...
White House declares April 2024 as Cancer Prevention and Early Detection Month This landmark announcement from the White House follows ongoing advocacy efforts, including a letter to President Joe Biden sent by Prevent Cancer Foundation, GLI, and 80 other advocacy...
Healthy Eating, Healthy Liver: The Links Between Nutrition and Liver Wellness Maintaining optimal liver health is crucial, given the liver's pivotal role as a major detoxifying organ. The liver, being a primary filter of toxins and chemicals that pass through...
